Giles Platford on Takeda’s 5 Year Deal with WFH for The Humanitarian Aid Program!
Giles Platford, President, Plasma-Derived Therapies Business Unit at Takeda and Chair of the Global Executive Board at PPTA, reposted from World Federation of Hemophilia on LinkedIn:
”I’m proud to share this important milestone: Takeda has renewed its 5-year agreement with the WFH and WFH_USA—furthering our support for the WFH Humanitarian Aid Program!
Together with other partners, we are working to expand access, drive equity, and change lives for people living with inherited bleeding disorders globally.”
Quoting World Federation of Hemophilia‘s post:
”The WFH and WFH USA are pleased to announce that Takeda has signed a 5-year agreement renewal with the WFH Humanitarian Aid Program from 2026 to 2030!
The agreement is for the donation of treatment product, as well as a financial commitment to cover it’s handling, storage and shipping. Learn more.”
Stay updated with Hemostasis Today.
-
Jun 22, 2026, 21:06Marios Bantidos: Can a Routinely Available Metabolic Index Improve Prediction of Angiographic Outcomes in STEMI?
-
Jun 22, 2026, 20:53Kirti Gupta: What is a DVT Scan?
-
Jun 22, 2026, 20:47Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS
-
Jun 22, 2026, 20:46Mohamed Abdel Moneim: Proud to Contribute to 2 Publications on Obesity and VTE Risk
-
Jun 22, 2026, 20:43Harshkumar Bhatiya: Stroke – Warning Signs, Prevention, and Immediate Medical Treatment
-
Jun 22, 2026, 16:45Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
-
Jun 22, 2026, 16:39Vikram Sinai Talaulikar: Haematology and Female Hormone Health Intersect at Multiple Levels
-
Jun 22, 2026, 16:35Sehrish Chaudhary: Advancing Transfusion Medicine Through Global Collaboration at ISBT 2026
-
Jun 22, 2026, 15:54Ready to Build Your ISTH 2026 Schedule?